BIOINTAXIS participated at the ATE26 conference in Barcelona from 7 to 9 September 2026.
Public source
Publisher name
Public post
BIOINTAXIS SL participating at #ATE26 in Barcelona, 7-9 September. Europe has the science. Now it needs the infrastructure, investment and commercial momentum to compete…
Company
BIOINTAXIS
Changing the paradigm in Friedreich's ataxia
- Industry
- Biotechnology Research
- Location
- Badalona, ES
- Company size
- 2–10 employees
About BIOINTAXIS
Biointaxis is an academic spin-off focused on the development of gene therapies for neurodegenerative disorders. Biointaxis lead product is a gene therapy product for Friedreich ataxia.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
NewBiologix
NewBiologix is attending the Advanced Therapies Europe 2026 conference in Barcelona.
Presence & Recognition
BioIVT
BioIVT is attending the BIOSPAIN2026 conference with an expert team including Imola Juhász, PhD, Jordi Xapelli, and Pol Pujal at booth #87.
Presence & Recognition
Artis BioSolutions
Artis BioSolutions participated in the Advanced Therapies Europe event at InterContinental Barcelona from 7 to 9 September with Ana Ricobaraza Abarquero Ph. D., Kris Ward, and José Vicente Pons Andreu presenting on Synthetic DNA.
Presence & Recognition
QuTEM
QuTEM is attending the Advanced Therapies Europe conference in Barcelona from 7 to 9 September 2026.
Presence & Recognition
Apertura Gene Therapy